Response to the Letter to the Editor: “Reaffirming Caution—The Unacceptable Vasoconstrictive Risk of CGRP ‐Related Therapies in Moyamoya Angiopathy”

European Journal of Neurology 2026 Open access

Read full text
Authors: Nicola Rifino, Anne Hege Aamodt, Markus Karl Hermann Wiedmann, Markus Kramer, Jana Becker, Stéphanie Guey, Francesco Acerbi, Dominique Hervé, Anna Bersano
DOI: 10.1111/ene.70470
Cited by: 0
References: 3

Fields of Study & Subjects

Moyamoya disease diagnosis and treatment Cerebrovascular and genetic disorders Neuroinflammation and Neurodegeneration Mechanisms

Publication details

Journal / source
European Journal of Neurology
Volume
33
Issue
1
Pages
e70470–e70470
Publication date
1 January 2026
Language
EN